Study type: In vivo/preclinical · Verification: Citation verified
The Potency of Semax Peptide Therapy toward MDA Level and Protein Profile in Epilepsy Rats (Rattus norvegicus)
Proceedings of the 1st International Conference in One Health (ICOH 2017) · 2018
Study scale: Not reported in the declared source.
Bibliographic details only: Open source record
Product or molecular entity relationships
- Semax: Catalog source association. Legacy citation custody associates this source with the catalog record; no product-relevance conclusion is implied.
No public summary
No plain-language summary is published in this record. Summary availability is separate from its verification. Consult the cited publication when a public link is available.
Limitations and uncertainty
Not reported in the declared source.
Citation verified. The DOI shown was confirmed at Crossref on 2026-08-20, and its study type matched the catalog’s source record. It is held as a citation, not evidence. No tier is an endorsement, an evidence-strength rating, or independent replication, and none establishes efficacy, safety, or suitability.